China pledges 400,000 doses of Sinopharm vaccine to Afghanistan
China has pledged 400,000 doses of the WHO approved Sinopharm vaccine to Afghanistan to assist in vaccination campaign
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.China has pledged to deliver 400,000 doses of Sinopharm’s COVID-19 vaccine to Afghanistan, Afghan officials said on Monday, in a boost for an immunisation campaign begun last week.
“China’s ambassador to Kabul said in a meeting with health officials that his country would provide Afghanistan with 400,000 doses of COVID-19 vaccine,” Ghulam Dastagir Nazari, the health ministry’s head of the immunisation programme, told Reuters.
The Sinopharm vaccine produced in China has been approved by the World Health Organization, but it is unclear when it will be delivered, Mr Nazari said.
So far just over 12,000 health workers have received the vaccine in all 34 provinces of Afghanistan, he said.
The vaccination of members of the security forces has also begun, according to another official, who spoke on condition of anonymity as they were not authorised to speak to media.
Afghan government forces are facing intensified attacks, blamed on Taliban insurgents, since September, when the two sides entered U.S.-brokered peace talks hosted by Qatar. The Taliban has largely denied responsibility for the rash of violence. The militant group has also said it supports the vaccination campaign.
Afghanistan has already received 500,000 doses of the AstraZeneca vaccine from India, which enabled the nation to launch its vaccination drive last Tuesday.
Afghan health officials have said that the international COVAX programme, which is aimed at improving access to the COVID-19 vaccine for developing countries, would provide vaccines to cover 20 per cent of the country’s 38 million population.
Afghanistan has registered 55,733 infections and 2,444 deaths. But experts say cases are significantly under-reported due to low testing and limited access to medical facilities in the war-torn country.
Reuters
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments